English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
Robert Lawson | Mar 9, 2017

AMA writes amicus brief to support proper medical testimony

+ Regulatory
Gene Johnson | Mar 9, 2017

FDA approves Qtern for treatment of Type 2 diabetes

+ Community
Gene Johnson | Mar 9, 2017

Aurinia Pharmaceuticals CEO speaks at health care conference

+ Community
Gene Johnson | Mar 9, 2017

Registration open for National Psoriasis Foundation's biennial conference

+ Community
Gene Johnson | Mar 9, 2017

Survey shows diabetics unaware of increased risk for serious illnesses

+ Regulatory
Erianne Leatherman | Mar 8, 2017

Study reveals adolescents with Type 2 diabetes more susceptible to complications

+ Technology/Innovation
Gene Johnson | Mar 8, 2017

Merck releases preliminary results of shingles vaccine

+ Community
Carol Ostrow | Mar 8, 2017

Sleepovers with non-custodial parent found to be jointly beneficial

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 399
  • 400
  • 401
  • 402
  • 403
  • 404
  • 405
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily